Clinical Trials Browser

Phase NA × Rivaroxaban × CNS × Clear all

NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Phase NA Unknown

CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism